Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,046 | 21,393 | 26,190 | 32,150 | 37,875 |
| TOTAL | $16,339 | $21,477 | $26,501 | $32,588 | $38,444 |
| Non-Current Assets | |||||
| PPE Net | 6 | 8 | 11 | 14 | 22 |
| TOTAL | $6 | $8 | $11 | $14 | $22 |
| Total Assets | $16,345 | $21,485 | $26,512 | $32,602 | $38,466 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,623 | 1,969 | 1,806 | 2,159 | 1,159 |
| Accrued Expenses | 483 | 949 | 685 | 699 | 793 |
| TOTAL | $2,106 | $2,918 | $2,491 | $2,858 | $1,952 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,106 | $2,918 | $2,491 | $2,858 | $1,952 |
| Shareholders' Equity | |||||
| Common Shares | 24 | 24 | 24 | 24 | 24 |
| Retained earnings | -307,100 | -302,256 | -295,985 | -289,380 | -281,589 |
| Other shareholders' equity | -380 | -380 | -380 | -380 | -380 |
| TOTAL | $14,239 | $18,567 | $24,021 | $29,744 | $36,514 |
| Total Liabilities And Equity | $16,345 | $21,485 | $26,512 | $32,602 | $38,466 |